143 related articles for article (PubMed ID: 8313612)
1. Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness.
Lenox RH; Watson DG
Clin Chem; 1994 Feb; 40(2):309-14. PubMed ID: 8313612
[TBL] [Abstract][Full Text] [Related]
2. Neurobiology of lithium: an update.
Lenox RH; McNamara RK; Papke RL; Manji HK
J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936
[TBL] [Abstract][Full Text] [Related]
3. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
4. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Watson DG; Watterson JM; Lenox RH
J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
[TBL] [Abstract][Full Text] [Related]
5. Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation.
Watson DG; Lenox RH
J Neurochem; 1996 Aug; 67(2):767-77. PubMed ID: 8764606
[TBL] [Abstract][Full Text] [Related]
6. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness.
Manji HK; Lenox RH
Biol Psychiatry; 1999 Nov; 46(10):1328-51. PubMed ID: 10578449
[TBL] [Abstract][Full Text] [Related]
7. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C.
Manji HK; Lenox RH
Synapse; 1994 Jan; 16(1):11-28. PubMed ID: 8134897
[TBL] [Abstract][Full Text] [Related]
8. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus.
Lenox RH; Watson DG; Patel J; Ellis J
Brain Res; 1992 Jan; 570(1-2):333-40. PubMed ID: 1617424
[TBL] [Abstract][Full Text] [Related]
9. Overview of the mechanism of action of lithium in the brain: fifty-year update.
Lenox RH; Hahn CG
J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
[TBL] [Abstract][Full Text] [Related]
10. Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.
Manji HK; McNamara R; Chen G; Lenox RH
Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S65-83. PubMed ID: 10622182
[TBL] [Abstract][Full Text] [Related]
11. Ziskind-Somerfeld research Award. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders.
Avissar S; Schreiber G
Biol Psychiatry; 1992 Mar; 31(5):435-59. PubMed ID: 1581423
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.
Lenox RH; Wang L
Mol Psychiatry; 2003 Feb; 8(2):135-44. PubMed ID: 12610644
[TBL] [Abstract][Full Text] [Related]
13. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness.
Moore GJ; Bebchuk JM; Parrish JK; Faulk MW; Arfken CL; Strahl-Bevacqua J; Manji HK
Am J Psychiatry; 1999 Dec; 156(12):1902-8. PubMed ID: 10588403
[TBL] [Abstract][Full Text] [Related]
14. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
15. [On the relevance of protein kinase C to lithium therapy in bipolar disorder].
Sela B
Harefuah; 2004 Jun; 143(6):414-6, 462. PubMed ID: 15524097
[TBL] [Abstract][Full Text] [Related]
16. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review.
Emilien G; Maloteaux JM; Seghers A; Charles G
Arch Int Pharmacodyn Ther; 1995; 330(3):251-78. PubMed ID: 8836446
[TBL] [Abstract][Full Text] [Related]
17. Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences.
Nahorski SR; Ragan CI; Challiss RA
Trends Pharmacol Sci; 1991 Aug; 12(8):297-303. PubMed ID: 1658998
[TBL] [Abstract][Full Text] [Related]
18. How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory.
Belmaker RH; Bersudsky Y; Agam G; Levine J; Kofman O
Annu Rev Med; 1996; 47():47-56. PubMed ID: 8712796
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action.
Divish MM; Sheftel G; Boyle A; Kalasapudi VD; Papolos DF; Lachman HM
J Neurosci Res; 1991 Jan; 28(1):40-8. PubMed ID: 1674966
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction pathways. Molecular targets for lithium's actions.
Manji HK; Potter WZ; Lenox RH
Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
